Microvascular, biochemical, and clinical impact of hyperbaric oxygen therapy in recalcitrant diabetic foot ulcers

Background: Diabetic foot ulcers (DFUs) are a serious complication of diabetes and are often difficult to treat. Hyperbaric oxygen therapy (HBOT) has been proposed as an adjunctive treatment to promote healing, but its long-term clinical and biological effects remain insufficiently characterized. This study aimed to evaluate the impact of HBOT on systemic biomarkers, local microvasculature, and clinical outcomes in patients with DFUs. Methods: In this non-randomized prospective study, 20 patients with ischemic DFUs were followed over a 36-month period. Fourteen received HBOT in addition to standard care, while six received standard care alone. Clinical outcomes—including DFU resolution, recurrence, lower extremity amputation (LEA), and mortality—were assessed alongside systemic inflammatory and angiogenic biomarkers and wound characteristics at baseline and at 3, 6, 12, and 36 months. CD31 immunostaining was performed on available tissue samples. Results: The two groups were comparable at baseline (mean age 62 ± 12 years; diabetes duration 18 ± 9 years). At 3 months, the HBOT group showed significant reductions in erythrocyte sedimentation rate and DFU size (p < 0.05), with downward trends observed in C-reactive protein (CRP), vascular endothelial growth factor (VEGF), and placental growth factor (PlGF), and an increase in stromal-derived factor-1 alpha (SDF1-?). No significant changes were observed in the control group. CD31+ microvessel density appeared to increase in HBOT-treated DFU tissue after one month, although the sample size was limited. Patients receiving HBOT had lower rates of LEA and mortality, improved wound healing, and sustained outcomes over three years. DFU recurrence rates were similar between groups. Conclusions: HBOT was associated with improved wound healing and favorable biomarker profiles in patients with treatment-resistant ischemic DFUs. While these findings are encouraging, the small sample size and non-randomized design limit their generalizability, highlighting the need for larger, controlled studies.

Keywords

Angiogenesis Diabetes Diabetic foot Foot ulcer Hyperbaric oxygen therapy Microvessel density

URI

http://hdl.handle.net/10400.14/54747

Citation

Martins-Mendes, D., Costa, R., Rodrigues, I., & Camacho, Ó. et al. (2025). Microvascular, biochemical, and clinical impact of hyperbaric oxygen therapy in recalcitrant diabetic foot ulcers. Cells, 14(15), Article 1196. https://doi.org/10.3390/cells14151196

DOI

10.3390/cells14151196

Collections

CBQF - Contribuições em Revistas Científicas / Contribution to Journals

CC License

cclicense-by

Altmetrics

Full item page